Your attorney mentions Track One. Pay an extra fee, get a decision inside about a year[1] instead of two or three.[4] For a company that needs the patent for a raise, a partnership, or a filing deadline tied to a product launch, that sounds like an easy yes. The fee shows up on an invoice as a line item next to the rest of the filing costs, framed as a straightforward upgrade: pay more, wait less.
It can also be the reason the claims that come out the other end are narrower than they needed to be.[3] By the time anyone notices, the case has already issued, the invoice has already been paid, and there is no obvious moment where the tradeoff was ever actually made.
The Myth
The myth is that expedited examination is a pure speed upgrade. You pay more, you wait less, and everything else about the process stays the same. Special status just means the case moves to the front of the line.
Why the Belief Holds
“Front of the line” is technically accurate, so the belief has a real foundation. Track One puts an application on a 12-month final-disposition target, and the USPTO tracks that publicly.[1] Nothing about the fee schedule mentions claim scope, so there’s no obvious reason to connect the two.[5] The petition form asks for a fee and a handful of formalities.[6] What the company gives up in exchange never appears on that form. It shows up later, as a downstream effect of how the examiner has to manage the accelerated docket.
This next observation is practitioner experience, not published data: I have read file wrappers where the claims allowed under Track One are noticeably narrower than what the specification could have supported, with the timing lining up against the accelerated docket. It is consistent with the published research on what happens to examination outcomes when examiner time is compressed.[3] Almost nobody sets out to draft a narrow claim. The docket makes it the path of least resistance.
The Mechanism
Track One puts the application on a docket with a strict internal deadline. The examiner has a fixed number of days to act, no exceptions.[1] Every accelerated-examination program the USPTO runs is negotiated against examiner workload, because moving one case ahead of the queue means something else on that examiner’s docket gets pushed back. Examiners are evaluated against a production-count system tied to examining hours, not a fixed calendar, so an accelerated case has to be worked inside that same finite time budget rather than getting extra hours allocated to it.[7] The examiner still has to do the same work on the accelerated case: read the specification, check the figures against the claims, find the point of novelty, search the prior art, and build a rejection or an allowance, all inside a window that leaves far less room to do it.
Faster and more thorough are not free to trade against each other. Peer-reviewed research tracking individual examiners across the promotions that cut their allotted examination hours found that less time consistently means less search effort and a higher grant rate on the margin, not a proportional cut across every task equally.[3] When an examiner has less time to fully work a case, the fastest path to closing it is either a quick allowance of claims narrow enough that there’s little left to argue about, or a rejection that moves the case toward a final action and off the accelerated docket. Neither of those outcomes is the examiner acting in bad faith. Both are a predictable result of compressing the time available for the same amount of work.
Track One also caps how much claim territory you can put in front of the examiner in the first place: the program limits an application to four independent claims and thirty claims total, with no multiple dependent claims allowed.[1] That cap exists to keep the accelerated docket manageable, but it means you are negotiating a narrower claim set from the outset, before the compressed-timeline pressure even enters the picture.
Track One status is not permanent, either. By rule, special status lasts only until final disposition of the application, not for the life of prosecution.[8] If that final disposition is a rejection rather than an allowance, the fee is not fully spent: you can request continued examination and pay for expedited treatment of that request too.[1] Some companies do this more than once on the same application, paying the acceleration fee at each stage without stopping to ask whether the deadline that justified the first payment still applies to the third one.
The Patent Prosecution Highway runs on a different mechanism entirely. PPH grants fast-track status once another participating patent office, or the PCT process, has already found corresponding claims allowable.[2] Unlike Track One, whose special status is defined by rule to run only until final disposition of the application,[8] the MPEP does not attach any such pendency target or expiration to PPH status.[2] That changes the examiner’s incentive: since the case is not being measured against a 12-month clock the way a Track One case is, there’s more room for a real back-and-forth on claim language before anything gets narrowed or rejected. The applicant can lean on the fact that another examining authority has already worked through the same technology, and the U.S. examiner isn’t racing a clock that rewards closing the case over refining it. The examiner also isn’t working from a blank slate. They can see what another office already found allowable, which is a genuine head start rather than just a shorter deadline.
What Track One Actually Costs
Run the numbers side by side and the case for paying for Track One at all gets weaker.
The Track One-specific fees, on top of ordinary filing costs, are the prioritized-examination fee plus a processing fee: $1,866 for a small entity, $4,665 for a large entity.[5] Filing a PCT application costs a transmittal fee, a search fee, and the international filing fee paid to WIPO: roughly $2,600 to $2,750 for a small entity, and around $4,350 for a large entity, depending on which office searches it.[5] Those numbers land in the same range. For close to what Track One costs, the company could have a PCT application instead: a year of international priority, an independent search and Written Opinion on patentability, and the option to enter any of over 150 member countries later.
Requesting PPH itself costs nothing. There is no USPTO fee for a PPH request.[10] So the real comparison is not Track One versus PPH. It is: pay for speed alone, or pay about the same amount and get speed plus a PCT application that PPH accesses for free.
That reframes two common patterns as bad tradeoffs rather than reasonable choices.
The first is filing a provisional application, then paying for Track One once the nonprovisional finally gets filed. A provisional is never examined; it exists only to hold a filing date while the applicant waits up to twelve months to file the real application.[11] Paying to accelerate examination after intentionally delaying its start by up to a year is working against your own timeline with your own money.
The second is filing a PCT application and a Track One request on the same case at the same time. That pays for both programs and gets the benefit of neither: the PCT search hasn’t come back yet, so there’s nothing for Track One’s compressed docket to lean on, and the accelerated clock is already running while the more useful, examiner-tested basis for PPH is still months away. The sequencing that actually captures the discount is to file the PCT first, wait for the international search report, which by rule issues within three months of the search copy reaching the searching authority or nine months from the priority date, whichever is later (in practice, close to three months when the USPTO is both receiving office and searching authority on a first filing),[9] and then use a favorable result to request PPH.[10] Same cost. A comparable timeline. No claim-count cap, no compressed docket, and a PCT application in hand instead of nothing.
A Track One request, on its own, is often a signal worth noticing. An attorney who reaches for it instead of routing through PCT and PPH is charging the client for speed the client could have gotten for close to the same money, plus a PCT application, by sequencing the filing differently.
One more timing signal worth watching: a Track One allowance that lands in September deserves a second look. The USPTO’s fiscal year ends September 30, examiner bonuses are tied to hitting production-count goals by then, and a first-action allowance pays more counts for less examiner work than a rejection does. That is one of the same production incentives that makes a compressed Track One docket push toward quick allowances in the first place, now stacked with the fiscal-year-end rush.[12]
What Excellent Looks Like
The CEOs who get this right don’t ask their attorney “how do we go faster?” They ask which mechanism matches what the company actually needs from the timeline, and they ask it before authorizing the fee, not after the claims come back narrower than expected. This matches the USPTO’s own guidance for getting the most out of the program: know the prior art well enough to file a complete claim schedule, from the broadest claim you believe is patentable to the narrowest you’re willing to accept, before the accelerated clock starts running.[1]
If a real deadline requires an issued patent by a specific date (a financing round, a licensing negotiation, litigation timing), Track One’s speed may be worth accepting a narrower claim to hit it. That’s a legitimate, deliberate tradeoff, made case by case.
If the goal is the strongest claims a specification can support, and there’s already a foreign or PCT filing that could clear examination elsewhere first, PPH gets a comparable timeline without the same pressure toward narrow allowance. The PCT costs that make PPH available are often costs a company planning international protection would pay anyway. PPH doesn’t add much on top of a filing strategy that was already justified on its own terms.
The claim-count cap matters here too. Because Track One limits how many independent claims go in front of the examiner, it forces the prioritization decision up front: which two or three claim directions matter enough to spend the accelerated slots on. PPH doesn’t impose that same ceiling, so a broader claim set can go through examination together, with the strongest ones surfacing from a real back-and-forth rather than from a cap that was set before anyone knew what the examiner would find in the prior art.
The RCE decision deserves the same scrutiny as the original filing decision, not a reflexive repeat of it. Paying to expedite an amendment after a final rejection makes sense when the deadline that justified the first fee is still live. It’s a separate cost that needs its own justification when that deadline has already passed, or when the goal has shifted from “issued by a date” to “the strongest claims we can get.”
Either way, the choice belongs at the same level as the rest of the filing strategy, tied directly to what the patent has to do for the business.
The claim-scope cost also doesn’t stay contained to the one patent it was paid on. A narrower granted claim is what shows up years later when an acquirer’s counsel maps the portfolio against your product line, or when a lender scores the patents you’re offering as collateral. Neither of them asks whether the narrowing happened because of Track One. They just see the claim scope that exists today, and price the patent accordingly.
The Takeaway
Before paying for expedited examination, ask what the compressed timeline does to the examiner’s incentives, and what it does to the calendar. Track One buys speed at the cost of room to negotiate. PPH buys comparable speed while keeping that room. Which one is right depends on whether a hard date or claim strength matters more for this specific patent.
That’s a filing-strategy decision, made with the same rigor as the rest of the budget. It is not a box an attorney checks on your behalf while you’re focused on the raise or the launch the patent is tied to. If you’ve already paid a Track One fee and aren’t sure what it cost you in claim scope, that’s worth a short conversation before the next application goes out.
1 MPEP § 708.02(b) — Prioritized Examination (Track One), including the USPTO Track One Data dashboard it feeds. Covers the 12-month average-final-disposition target, the four-independent/thirty-total claim limit with no multiple dependent claims, the availability of prioritized treatment for a request for continued examination, and the USPTO’s own guidance on filing a complete broadest-to-narrowest claim schedule to get the most out of the program. ↩
2 MPEP § 708.02(c) — Patent Prosecution Highway Program. The section states the fast-track mechanism (a foreign or PCT allowance triggers eligibility) but, unlike § 708.02(b), states no pendency target or deadline for PPH cases. ↩
3 Michael D. Frakes & Melissa F. Wasserman, Is the Time Allocated to Review Patent Applications Inducing Examiners to Grant Invalid Patents? Evidence from Micro-Level Application Data, NBER Working Paper No. 20337. Tracking individual examiners across the General Schedule promotions that cut their allotted examination hours, the study finds less time is associated with reduced search effort and a higher grant rate on the margin. ↩
4 USPTO Patents Dashboard — Pendency. Traditional total pendency including RCEs has run 28–34 months (roughly 2.3 to 2.8 years) over FY2020–YTD FY2026. ↩
5 USPTO Fee Schedule, current as read. None of the fees are conditioned on or vary with claim scope. Track One-specific fees: prioritized-examination fee (37 CFR 1.17(c)) $4,515 / $1,806 (small) / $903 (micro), plus processing fee (37 CFR 1.17(i)(1)) $150 / $60 / $30 — totaling $4,665 large entity, $1,866 small entity. PCT filing-specific fees: transmittal fee (37 CFR 1.445(a)(1)(i)(A)) $285 / $114 / $57, search fee where USPTO is the ISA (37 CFR 1.445(a)(2)(i)) $2,400 / $960 / $480, plus the international filing fee paid to WIPO (first 30 pages) $1,667 standard or $1,416-1,542 filed electronically — totaling roughly $4,352 large entity, $2,616-2,742 small entity (WIPO’s international filing fee is not itself entity-fee-reduced). ↩
6 BlueIron, What are the requirements for a complete request for prioritized examination? ↩
7 USPTO Patent Examiner Count System. Examiners earn “counts” toward production goals set from their allotted examining hours; a 2025 GAO review found the count system continues to drive examiners to shortchange time-intensive work such as full prior-art searches. GAO-25-107218. ↩
8 MPEP § 708.02(b) — Prioritized Examination, rule “Application Under Priority Exam Must Be Disposed Within 12 Months”: “Under prioritized examination, an application will be accorded special status until a final disposition is reached in the application. The goal for handling applications under prioritized examination is to provide, on average, a final disposition within twelve months of prioritized status being granted.” ↩
9 MPEP § 1842 — Basic Flow Under the PCT: “the time limit for establishing the international search report … and written opinion is three months from the receipt of the search copy by the International Searching Authority, or nine months from the priority date, whichever time limit expires later” (PCT Rule 42, PCT Rule 43bis). Where there is no earlier priority claim, the international filing date is the priority date. ↩
10 USPTO, Patent Prosecution Highway (PPH) — Fast Track Examination of Applications: “There is no fee under the PPH programs.” A favorable Written Opinion of the ISA or IPER on a PCT application is an accepted PCT-PPH work product for requesting fast-track examination in participating offices, including the USPTO. ↩
11 MPEP § 201.01 — Types of Applications, rule “Provisional Applications Not Examined for Patentability.” A provisional application is never examined; it only preserves a filing date, and a corresponding nonprovisional must be filed within twelve months to claim its benefit. ↩
12 Russ Krajec, Why patents in September are a bad thing, BlueIron IP (Mar. 22, 2021), citing the USPTO Examiner Performance Appraisal Plan’s count table: a first-action allowance earns 2.00 counts against 1.25 for a first-action rejection, and production goals are 34% of an examiner’s evaluation, with bonuses tied to exceeding them by fiscal year end (September 30). ↩
